Madison Avenue Partners, LP
Q2 2025 13F Holdings
- Locationnew york, NY
- Num holdings
26
- Value ($000)
$1,497,802
- Date Filed08/14/2025
- Form type13F-HR
- CIK0001801265
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
GRAHAM HLDGS CO | COM CL B | 384637104 | $232.07M | 16 % | 245,271 | ||
SOLV SOLVENTUM CORP | COM SHS | 83444M101 | $170.21M | 11 % | 2,244,344 | ||
MKL MARKEL GROUP INC | COM | 570535104 | $168.40M | 11 % | 84,310 | ||
SANDISK CORP | COM | 80004C200 | $161.95M | 11 % | 3,571,109 | ||
INDIVIOR PLC | ORD | G4766E116 | $116.77M | 8 % | 7,922,178 | ||
THERAVANCE BIOPHARMA INC | COM | G8807B106 | $104.91M | 7 % | 9,511,150 | ||
GMED GLOBUS MED INC | CL A | 379577208 | $101.05M | 7 % | 1,712,148 | ||
WLY WILEY JOHN & SONS INC | CL A | 968223206 | $91.61M | 6 % | 2,052,696 | ||
SAGE SAGE THERAPEUTICS INC | COM | 78667J108 | $55.42M | 4 % | 6,077,065 | ||
GLPG GALAPAGOS NV | SPON ADR | 36315X101 | $52.54M | 4 % | 1,877,011 |
Rows Per Page
10
- 10
- 50
- 100